Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
'Mission: Impossible' Projected to Earn $250M in Five Days
'Mission: Impossible' Projected to Earn $250M in Five Days
Microsoft Wins Court Bid Over Activision Deal
Microsoft Wins Court Bid Over Activision Deal
Burger King Introduces 'Real Cheeseburger' in Thailand
Burger King Introduces 'Real Cheeseburger' in Thailand
What Amazon Operations Look Like on Prime Day
Amazon is expected to pull in about $7 billion in revenue during this year's Prime Day, according to projections. Cheddar News took a peek at some of the top-selling items and what operations look like at one of its plants.
Berkshire Hathaway Takes Control of Maryland LNG Plant in $3.3B Deal
Warren Buffett's Berkshire Hathaway increased its stake in an LNG plant in Maryland for $3.3 billion as it doubles down on fossil fuels.
Threads App Predicted to Generate $8B in Annual Revenue
Threads could bring in $8 billion in annual revenue, according to analysis, after it reached about 100 million users days after its launch. Cheddar News explains.
Be Well: How Rising Interest Impacts Corporate Default Rates
Be Well: How Rising Interest Impacts Corporate Default Rates
Bank of America Fined Over $100M for Doubling Fees, Opening Accounts Without Customer Consent
Bank of America must pay more than $100 million to customers for doubling up on some fees, withholding reward bonuses and opening accounts without customer consent.
On the Scene: Visiting an Amazon Warehouse Ahead of Prime Day
Cheddar News Senior Reporter Michelle Castillo visited an Amazon warehouse on Long Island to get a behind-the-scenes look at the company's efforts ahead of Prime Day.
